Health Talk America
Dolly Parton's Legacy, Turbo Cancers, and Google's New Glucose Monitor Deal with Dr. David Heitmann
This three-hour edition of Health Talk America traces Dolly Parton's health legacy and sudden passing alongside Tim Curry's, digs into disputed "turbo cancer" claims, and sits down with Dr. David Heitmann to unpack Google and Abbott's new glucose-monitoring partnership.
Remembering Dolly Parton's Discipline and Legacy
Dr. Adam Brockman opens the show by welcoming Dr. Bob Martin back to the microphone and framing the hour's centerpiece: the life, health and legacy of Dolly Parton. Brockman notes that Parton spent more than sixty years touring, recording and performing under bright lights, a pace he says would break most people within a decade, yet she kept working into her late seventies with the energy of someone half her age. Martin says he loved her music and her charity work, including Dollywood, and calls her one of the most beloved country performers of all time. The conversation quickly turns pointed as Martin recalls Parton's public partnership with Moderna during the COVID pandemic, where she filmed herself receiving a vaccine dose and, according to Martin, suggested people who declined a shot were cowards. He compares her to other celebrities who promoted products or advice he considers misguided, including Jennifer Aniston and Howard Stern, and argues that fame should never substitute for a trusted doctor's guidance.
A Fast-Moving Cancer and Turbo Cancer Claims
Brockman shifts to the undisclosed cancer diagnosis Parton received later in life, noting that her treatment moved quickly but that the exact type was never made public. Martin questions whether Parton understood the experimental nature of the COVID shot she promoted, then says she was reportedly using experimental cancer therapies at the time of her death. He cites unnamed oncologists who estimate chemotherapy's long-term survival benefit at only one to three percent and argues that Pfizer, despite nearly two centuries in business, has never produced an outright disease cure. Martin also raises the disputed idea of turbo cancers, claiming some oncologists have observed COVID vaccination reawakening or accelerating cancers in remission, while stressing he is relaying other doctors' observations rather than his own diagnosis. Brockman counters with clinical nuance, explaining that fast-growing cancers behave differently than slow ones and urging listeners not to delay screenings. The two then pivot to a warmer note, praising Parton's 1995 founding of the Imagination Library and its link to childhood literacy and lifelong health literacy.
A Listener's Trip to a Holistic Clinic
Brockman reads a listener account from Donna, a Scottsdale woman who visited the Holistic Care Clinic in Tijuana for dental work and stayed for regenerative therapies, including EBOO, or ultraviolet blood oxygenation. She describes the staff as unhurried and says she left feeling more energized. Martin, who has visited the clinic twice with his wife and once with his ICU-nurse daughter, describes deep cleanings, dental implants at a fraction of United States prices, and a biodental department that removes mercury fillings using the Hal Huggins protocol. He recounts receiving intravenous laetrile as cancer prevention, high-dose vitamin C, glutathione, red light therapy and hyperbaric oxygen, joking that he felt decades younger and had to be reminded by his wife not to overdo it. A caller voicemail follows, thanking both hosts for never having taken a COVID shot and for their years of straight talk. Martin and Brockman respond by reaffirming that their role is to provide information, not directives, and to advocate for informed consent rather than mandates.
Dr. David Heitmann On Google's New Glucose Deal
The second hour brings Dr. David Heitmann into the studio to unpack Google and Abbott's new integration, which pipes data from Abbott's Lingo continuous glucose monitor directly into the Google Health dashboard. Heitmann explains that over-the-counter glucose monitors already helped many of the roughly 115 million prediabetic Americans discover their condition, and that combining that data with a platform as large as Google's dramatically lowers the barrier to entry. He walks Brockman through the difference between a one-time fasting glucose test, an A1C average and continuous real-time tracking, sharing the story of a client whose late-night anxiety and poor sleep turned out to be driven by nighttime hypoglycemia, resolved once he began eating protein before bed. Heitmann calls the monitor a smoke detector rather than a fire department, useful for flagging abnormal patterns but not a diagnosis on its own. He also addresses walking's outsized benefit on glucose control, data privacy tied to trusting Google generally, and predicts pre-visit wearable data kits could become standard within five to ten years.
This Week's Headlines and Two Cultural Losses
Opening the third hour, Brockman runs through the week's headlines: the FDA's approval of Raxan Q for advanced pancreatic cancer, which nearly doubled median survival in trials; a wave of recalls tied to frozen blueberries, ricotta cheese, eggs and jalapeños; Mayo Clinic research into gut bacteria signaling linked to IBS-related constipation; and viral fitness trends including the 6-6-6 walking challenge and a weekend-warrior study showing concentrated exercise still lowers mortality risk. Brockman then reflects on losing two cultural figures within a day of each other, Dolly Parton and Tim Curry, both dead at eighty. He contrasts Parton's brief, fast-moving cancer battle with Curry's fourteen years adapting his voice-acting career after a 2012 stroke, arguing that both modeled a refusal to let illness define their entire identity. He credits Parton's Imagination Library, which he says has distributed more than three hundred million free books, and Curry's willingness to keep performing despite lasting complications, framing both as lessons in purpose-driven aging rather than simple survival.
Health Alternative and the Turbo Cancer Mystery
For the Health Alternative of the Week, Brockman recommends Spry oral care products built around xylitol, arguing that starving cavity-causing bacteria is a better long-term strategy than sweeteners that simply mask bad breath, then circles back to the Lingo-Google integration as a proactive, non-prescription way to catch metabolic trouble early. The Health Mystery of the Week tackles turbo cancers directly. Brockman explains the term has no formal medical definition, but that some cancers are legitimately fast-growing by biology alone, citing triple-negative breast cancer and small-cell lung cancer as established examples that predate any pandemic. He also raises delayed screening during COVID as an alternative explanation for cancers appearing suddenly advanced, and acknowledges researchers have floated, without population-level proof, theories about immune modulation possibly interacting with dormant cancer cells after vaccination. Rather than offering a verdict, he urges listeners not to panic over the term, to keep routine mammograms and skin checks on schedule, and to report any persistent new symptom promptly rather than waiting it out.